Most employers have little idea what the pharmacy benefit managers they hire do with the money they exchange for the ...

Perioperative chemotherapy may be underused in patients with stage II-III esophageal cancer, according to researchers.

Gilead has made the decision to withdraw the accelerated approval of Trodelvy (sacituzumab govitecan) for advanced urothelial cancer in the United States.

Five-fraction SBRT is “a robust and viable alternative” to conventionally or moderately fractionated radiotherapy for prostate cancer, researchers say.

The policy of billing for patient portal messages changes patient expectations and can impact the patient-physician ...

Perioperative treatment with camrelizumab, low-dose rivoceranib, S-1, and oxaliplatin (SOXRC) appears safe and effective for ...

Nurses were more likely than other health care workers to favor using AI-generated responses to patient portal messages.

An analysis of AYA cancer survivors in the US revealed “a substantial population of aging, long-term cancer survivors,” according to researchers.

Redispensing unused oral cancer drugs can have a beneficial impact on climate change, ecosystems, and human health, a study ...

The FDA has approved Vyloy (zolbetuximab-clzb) in combination with chemotherapy to treat advanced gastric or GEJ cancer.

Psilocybin-assisted psychotherapy “has the potential to be a comprehensive mental health treatment for patients with cancer,” ...

Exposure to radon levels, even below current recommended levels, heightens the risk for childhood leukemia, a study suggests.